Ophthalmology · New York, NY
NPI
1003949322
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
111 Wadsworth Ave
New York, NY, 10033
Phone (646) 627-7544
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
807 services
Medicare patients, 2024
636
Average age 77
Drug cost, 2024
$6.3M
14,627 prescriptions
Company payments, 2025
$354
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward A Braunstein was code 99213 (office e&m - established), 607 times for 592 patients. In total Edward A Braunstein billed 807 services in 18 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 607 | 592 | $75.50 | $46K |
| 92014 Ophthalmological E&M | Office | 41 | 27 | $97.12 | $3,982 |
| 92250 Angiography | Office | 30 | 28 | $27.54 | $826 |
| 92083 Vision, Hearing, and Speech Services | Office | 27 | 24 | $49.06 | $1,325 |
| 92136 Ultrasound - Nonspecific | Office | 22 | 12 | $20.10 | $442 |
| 92133 Computerized Ophthalmic Imaging | Office | 19 | 15 | $25.83 | $491 |
| 92020 Ophthalmological E&M | Office | 18 | 18 | $19.07 | $343 |
By year: 2022 $37K for 374 services; 2023 $32K for 460 services; 2024 $56K for 807 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edward A Braunstein prescribed most often to Medicare patients was Xiidra (Lifitegrast), with 3,605 prescriptions and refills. In total Edward A Braunstein wrote 14,627 Medicare prescriptions that cost $6.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xiidra Lifitegrast | 3,605 | 3,956 | 730 | $2.6M |
| Latanoprost Generic | 2,785 | 3,339 | 544 | $17K |
| Restasis Cyclosporine | 2,006 | 2,531 | 446 | $1.5M |
| Iyuzeh Latanoprost/Pf | 962 | 1,467 | 321 | $409K |
| Vyzulta Latanoprostene Bunod | 884 | 1,039 | 188 | $290K |
| Miebo Perfluorohexyloctane/Pf | 762 | 1,013 | 250 | $734K |
| Brimonidine Tartrate Generic | 433 | 569 | 94 | $11K |
| Tyrvaya Varenicline Tartrate | 372 | 457 | 92 | $227K |
| Cyclosporine Generic | 333 | 477 | 101 | $93K |
| Combigan Brimonidine Tartrate/Timolol | 323 | 376 | 55 | $76K |
| Cequa Cyclosporine | 274 | 284 | 96 | $155K |
| Prednisolone Acetate Generic | 234 | 296 | 74 | $8,919 |
| Lumigan Bimatoprost | 220 | 244 | 40 | $59K |
| Ketorolac Tromethamine Generic | 219 | 263 | 70 | $3,737 |
| Ofloxacin Generic | 195 | 236 | 57 | $3,851 |
Brand drugs: 10,949 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward A Braunstein $354 ($354 in general payments such as food, travel and fees) from 5 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $151.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 8 | $151 |
| Mallinckrodt Hospital Products Inc. | 3 | $86.25 |
| Bausch & Lomb Americas Inc. BLCO | 3 | $52.97 |
| Oyster Point Pharma, Inc. | 2 | $39.19 |
| Thea Pharma Inc. | 1 | $23.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.